» Articles » PMID: 24912917

Transplantation and Inflammation: Implications for the Modification of Chemokine Function

Overview
Journal Immunology
Date 2014 Jun 11
PMID 24912917
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Oxidative stress is a major and recurring cause of damage during inflammation, especially following organ transplantation. Initial ischaemia-reperfusion injury causes the production of many reactive oxygen and nitrogen species, and subsequent recruitment and activation of inflammatory cells can lead to further oxidative stress. This stress is well known to cause damage at the cellular level, for example by induction of senescence leading to the production of a characteristic senescence-associated secretory phenotype. Chemokines are an important component of the senescence-associated secretory phenotype, recruiting further leucocytes and reinforcing the stress and senescence responses. As well as inducing the production of proteins, including chemokines, oxidative stress can alter proteins themselves, both directly and by induction of enzymes capable of modification. These alterations can lead to important modifications to their biological activity and also alter detection by some antibodies, potentially limiting the biological relevance of some immunochemical and proteomic biomarkers. Peroxynitrite, a reactive nitrogen species generated during inflammation and ischaemia, can cause such modifications by nitrating chemokines. Matrix metalloproteinases, released by many stressed cells, can cleave chemokines, altering function, while peptidylarginine deiminases can inactivate certain chemokines by citrullination. This review discusses the relationship between inflammation and post-translational modification, focusing on the functional modulation of transplant-relevant pro-inflammatory chemokines.

Citing Articles

Urinary Chemokines CXCL9 and CXCL10 Are Non-Invasive Biomarkers of Kidney Transplant Rejection.

Macioniene E, Simanavicius M, Vitkauskaite M, Vickiene A, Stauce R, Vinikovas A Ann Transplant. 2024; 29:e944762.

PMID: 39402819 PMC: 11490196. DOI: 10.12659/AOT.944762.


Cytokines Removal During Lung Perfusion: Initial Clinical Experience.

Boffini M, Marro M, Simonato E, Scalini F, Costamagna A, Fanelli V Transpl Int. 2023; 36:10777.

PMID: 37645241 PMC: 10460908. DOI: 10.3389/ti.2023.10777.


Mouse Models of Renal Allograft Transplant Rejection: Methods to Investigate Chemokine-GAG Interaction and Therapeutic Blockade.

Zanetti I, Zhang L, Burgin M, Kilbourne J, Yaron J, Fonseca D Methods Mol Biol. 2022; 2597:39-58.

PMID: 36374413 DOI: 10.1007/978-1-0716-2835-5_5.


Virus-Derived Chemokine Modulating Protein Pre-Treatment Blocks Chemokine-Glycosaminoglycan Interactions and Significantly Reduces Transplant Immune Damage.

Zanetti I, Burgin M, Zhang L, Yeh S, Ambadapadi S, Kilbourne J Pathogens. 2022; 11(5).

PMID: 35631109 PMC: 9144952. DOI: 10.3390/pathogens11050588.


Circulating CXCL10 and IL-6 in solid organ donors after brain death predict graft outcomes.

Piemonti L, Sordi V, Pellegrini S, Scotti G, Scavini M, Sioli V Sci Rep. 2021; 11(1):6624.

PMID: 33758270 PMC: 7988181. DOI: 10.1038/s41598-021-86085-6.


References
1.
Szabo C, Ischiropoulos H, Radi R . Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov. 2007; 6(8):662-80. DOI: 10.1038/nrd2222. View

2.
Mortier A, Van Damme J, Proost P . Regulation of chemokine activity by posttranslational modification. Pharmacol Ther. 2008; 120(2):197-217. DOI: 10.1016/j.pharmthera.2008.08.006. View

3.
Dong A, Shen J, Zeng M, Campochiaro P . Vascular cell-adhesion molecule-1 plays a central role in the proangiogenic effects of oxidative stress. Proc Natl Acad Sci U S A. 2011; 108(35):14614-9. PMC: 3167513. DOI: 10.1073/pnas.1012859108. View

4.
Urtasun R, Cubero F, Vera M, Nieto N . Reactive nitrogen species switch on early extracellular matrix remodeling via induction of MMP1 and TNFalpha. Gastroenterology. 2009; 136(4):1410-22, e1-4. DOI: 10.1053/j.gastro.2008.12.065. View

5.
. Peptidylarginine deiminases: physiological function, interaction with chemokines and role in pathology. Drug Discov Today Technol. 2013; 9(4):e227-314. DOI: 10.1016/j.ddtec.2012.06.002. View